Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about iSpecimen Inc.
iSpecimen Inc. News
iSpecimen Inc. Quantitative Score
About iSpecimen Inc.
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
iSpecimen Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
iSpecimen Inc. Financials
Table Compare
Compare ISPC metrics with: | |||
|---|---|---|---|
Earnings & Growth | ISPC | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | ISPC | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | ISPC | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | ISPC | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
iSpecimen Inc. Income
iSpecimen Inc. Balance Sheet
iSpecimen Inc. Cash Flow
iSpecimen Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Sell |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Neutral |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Buy |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
iSpecimen Inc. Executives
| Name | Role |
|---|---|
| Ms. Katharyn Field | President |
| Ms. Leslie Hoyt | Senior Vice President of Operations |
| Mr. Yuying Liang | Chief Financial Officer |
| Ms. Carly Lejnieks | Vice President of Marketing |
| Mr. Robert Bradley Lim | Chief Executive Officer, Treasurer, Secretary & Director |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Ms. Katharyn Field | President | Female | 1983 | 9.23K |
| Ms. Leslie Hoyt | Senior Vice President of Operations | Female | -- | |
| Mr. Yuying Liang | Chief Financial Officer | Male | -- | |
| Ms. Carly Lejnieks | Vice President of Marketing | Female | -- | |
| Mr. Robert Bradley Lim | Chief Executive Officer, Treasurer, Secretary & Director | Male | 1994 | -- |
iSpecimen Inc. Insider Trades
| Date | 13 Dec |
| Name | Liang Yuying |
| Role | Officer |
| Transaction | Disposed |
| Type | |
| Shares | 0 |
| Date | 9 Dec |
| Name | LIM ROBERT BRADLEY |
| Role | Chief Executive Officer |
| Transaction | Disposed |
| Type | |
| Shares | 0 |
| Date | 25 Sep |
| Name | Dhaliwal Avtar |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 168 |
| Date | 25 Sep |
| Name | Dhaliwal Avtar |
| Role | Director |
| Transaction | Disposed |
| Type | |
| Shares | 0 |
| Date | 25 Sep |
| Name | Paolone Richard |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 168 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 13 Dec | Liang Yuying | Officer | Disposed | 0 | |
| 9 Dec | LIM ROBERT BRADLEY | Chief Executive Officer | Disposed | 0 | |
| 25 Sep | Dhaliwal Avtar | Director | Acquired | A-Award | 168 |
| 25 Sep | Dhaliwal Avtar | Director | Disposed | 0 | |
| 25 Sep | Paolone Richard | Director | Acquired | A-Award | 168 |